We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
-8.41%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$22.8B
AUM Growth
-$4.41B
(-16%)
Cap. Flow
-$1.27B
Cap. Flow
% of AUM
-5.6%
Top 10 Holdings %
Top 10 Hldgs %
36.84%
Holding
614
New
135
Increased
158
Reduced
239
Closed
65
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$190M |
| 2 |
Lowe's Companies
LOW
|
+$187M |
| 3 |
Netflix
NFLX
|
+$179M |
| 4 |
Starbucks
SBUX
|
+$114M |
| 5 |
Novartis
NVS
|
+$92.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$260M |
| 2 |
Microsoft
MSFT
|
+$208M |
| 3 |
Salesforce
CRM
|
+$171M |
| 4 |
Dollar Tree
DLTR
|
+$171M |
| 5 |
Adobe
ADBE
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.16% |
| 2 | Healthcare | 22.78% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Communication Services | 9.78% |
| 5 | Financials | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Schrodinger
SDGR
$1.13B
| $574K | ﹤0.01% |
+13,301
| New | +$502K |
|
352
Ascendis Pharma A/S
ASND
$16B
| $563K | ﹤0.01% |
5,000
-500
| -9% | -$65K |
|
353
Adaptive Biotechnologies
ADPT
$3.59B
| $560K | ﹤0.01% |
20,171
-8,000
| -28% | -$223K |
|
354
Johnson Controls International
JCI
$88.8B
| $560K | ﹤0.01% |
20,761
-481
| -2% | -$17.9K |
|
355
StoneCo
STNE
$2.77B
| $551K | ﹤0.01% |
+25,300
| New | +$965K |
|
356
Idexx Laboratories
IDXX
$44.1B
| $548K | ﹤0.01% |
2,263
+257
| +13% | +$67.1K |
|
357
Hartford Financial Services
HIG
$38.9B
| $541K | ﹤0.01% |
15,349
-5,008
| -25% | -$261K |
|
|
ENV
358
DELISTED
ENVESTNET, INC.
ENV
| $539K | ﹤0.01% |
+10,014
| New | +$717K |
|
359
Allegion
ALLE
$13.4B
| $515K | ﹤0.01% |
5,600
| – | – |
|
360
MeiraGTx Holdings
MGTX
$1.09B
| $511K | ﹤0.01% |
38,000
+2,000
| +6% | +$33.8K |
|
361
Under Armour
UAA
$2.84B
| $493K | ﹤0.01% |
53,527
+52,953
| +9,225% | +$851K |
|
362
Tapestry
TPR
$30.8B
| $485K | ﹤0.01% |
37,443
-868
| -2% | -$20.3K |
|
363
Castle Biosciences
CSTL
$855M
| $477K | ﹤0.01% |
16,000
-6,000
| -27% | -$181K |
|
364
MSCI
MSCI
$41.6B
| $427K | ﹤0.01% |
1,476
+1,204
| +443% | +$341K |
|
365
Accenture
ACN
$102B
| $426K | ﹤0.01% |
2,611
-526
| -17% | -$101K |
|
366
Black Diamond Therapeutics
BDTX
$96.8M
| $424K | ﹤0.01% |
+17,000
| New | +$517K |
|
367
Akebia Therapeutics
AKBA
$354M
| $417K | ﹤0.01% |
+55,000
| New | +$428K |
|
368
Darden Restaurants
DRI
$23.3B
| $411K | ﹤0.01% |
7,546
-173
| -2% | -$16.8K |
|
369
TG Therapeutics
TGTX
$7.96B
| $403K | ﹤0.01% |
+41,000
| New | +$518K |
|
370
Xylem
XYL
$27.3B
| $374K | ﹤0.01% |
5,750
-384
| -6% | -$30.3K |
|
|
SDC
371
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $363K | ﹤0.01% |
77,829
-44
| -0.1% | -$434 |
|
372
Kroger
KR
$35.4B
| $358K | ﹤0.01% |
11,878
+1,828
| +18% | +$53.6K |
|
373
Electronic Arts
EA
$53B
| $352K | ﹤0.01% |
3,512
+168
| +5% | +$17.7K |
|
|
SAGE
374
DELISTED
Sage Therapeutics
SAGE
| $345K | ﹤0.01% |
12,000
-3,000
| -20% | -$174K |
|
375
Oneok
OKE
$57.2B
| $340K | ﹤0.01% |
15,600
-359
| -2% | -$21.9K |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q1 2020 Portfolio in Review
As of Q1 2020, Fred Alger Management held 614 positions worth $22.8B, down 16% from $27.2B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Fred Alger Management withdrew a net $1.27B in Q1 2020, closing 65 positions and reducing 239 holdings. Its most notable exit was Dermira, Inc., an estimated $46.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Fred Alger Management opened a new position in AtriCure worth $42.4M.
- Fred Alger Management's largest Q1 2020 buy was AtriCure: 1,263,408 shares worth $42.4M.
- Fred Alger Management added most to NVIDIA in Q1 2020, an estimated $190M increase.
- Fred Alger Management's biggest Q1 2020 reduction was Abbott, cutting an estimated $260M.
- Fred Alger Management fully exited Dermira, Inc. in Q1 2020, selling an estimated $46.3M.
- Fred Alger Management's ten largest holdings make up 37% of its $22.8B portfolio in Q1 2020.
- Fred Alger Management opened 135 new positions and closed 65 in Q1 2020.
- Fred Alger Management's portfolio value fell 16% quarter-over-quarter to $22.8B.
Based on Fred Alger Management's 13F filing for Q1 2020, filed 15 May 2020.